𝔖 Bobbio Scriptorium

✦ LIBER ✦

745 HEALTH RELATED QUALITY OF LIFE AND SYMPTOMS IN AN INTERNATIONAL PHASE III TRIAL OF LONG TERM VERSUS SHORT-TERM ANDROGEN SUPPRESSION AND RADIATION THERAPY FOR LOCALLY ADVANCED PROSTATE CANCER (EORTC TRIAL 22961)

✍ Scribed by L. Collette; M. Mauer; M. Bolla; G. Van Tienhoven; T.M. De Reijke; A.C.M. Van Den Bergh; J. Oddens; P.M.P. Poortmans; A. Bottomley

Book ID: 119620065
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 508 KB
Volume: 8
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(09)60737-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RTOG Protocol 05-18: A Phase III Randomi

RTOG Protocol 05-18: A Phase III Randomized Trial to Evaluate the Efficacy of Zoledronic Acid for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy (RT) and Long-term Luteinizing Hormone-releasing Hormone (LHRH) Agonist for High-grade and/or Locally Advanced Prostate Cancer

✍ Lawton, C.A.; Shook, S.; Smith, M.; Tripp, P.; Shah, A.B.; Martin, A.; Kim, H.E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase III trial of long-term adjuvant an

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02: Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group, Fox Chase Cancer Center and Radiation Therapy Oncology Group, Phialdelphia, PA

✍ Michael Zelefsky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 21 KB

Phase III trial of long-term adjuvant an

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02: Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group, Fox Chase Cancer Center and Radiation Therapy Oncology Group, Philadelphia, PA. J Clin Oncol 2004;22:386

✍ Gurkamal Chatta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Re: Liam Bourke, Stephen Gilbert, Richar

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial. Eur Urol 2014;65:865–72;Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856–64;Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O’Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer. Eur Urol 2014;65:816–24;Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol 2014;65:704–9

✍ Goonewardene, Sanchia S.; Persad, Raj; Young, Annie; Makar, Adel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 144 KB